|1.||Okada, David R: 1 article (01/2014)|
|2.||Okada, Robert D: 1 article (01/2014)|
|3.||Johnson, Gerald: 1 article (01/2014)|
01/01/2014 - "Thus, the purposes of this study were to use a canine model of ischemia-reperfusion to (1) compare Tc-99m-teboroxime clearance kinetics in normal and ischemic-reperfused myocardium and (2) assess the utility of Tc-99m-teboroxime clearance kinetics in determining the severity of injury following ischemia-reperfusion. "
01/01/2014 - "Tc-99m-teboroxime demonstrates moderate differential clearance in a model of severe injury with 120 min of ischemia-reperfusion, but only minimal differential clearance in a model of mild injury with 30 min of ischemia-reperfusion. "
01/01/2014 - "Tc-99m-teboroxime has demonstrated high myocardial extraction, linear myocardial uptake relative to flow even at high flow rates, rapid uptake and clearance kinetics, and differential clearance in the setting of ischemia. "
07/01/1992 - "The diagnosis of effort ischemia was made in 13 patients with Tc-99m-teboroxime and in 12 patients with TI-201. "
|2.||Coronary Disease (Coronary Heart Disease)
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
|4.||Chest Pain (Chest Pains)
|1.||Technetium Tc 99m Sestamibi (Cardiolite)